ORIGINAL_ARTICLE
Teratogenic Effects of Long Term Consumption of Potassium Benzoate
on Eye Development in Balb/c Fetal Mice
https://ijbms.mums.ac.ir/article_717_2d6d87f01a4d1aef8a028ce9ceaf1d96.pdf
2013-04-01
593
598
10.22038/ijbms.2013.717
Keywords:
Eye Development
Mice Fetuses
Potassium Benzoate
Teratogenicity
Mohammad
Afshar
1
Department of Anatomy, Faculty of Medicine, Birjand University of Medical Sciences, Birjand, Iran
2 Medical Toxicology Research Centre, Mashhad University of Medical Sciences, Mashhad, Iran
AUTHOR
Seyed Adel
Moallem
2
Medical Toxicology Research Centre, Mashhad University of Medical Sciences, Mashhad, Iran
3Department of Pharmacodynamics and Toxicology, school of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran
AUTHOR
Jina
Khayatzadeh
3
Department of Biology, Faculty of Basic Sciences, Mashhad Branch, Islamic Azad University, Mashhad, Iran
AUTHOR
Marziyeh
Shahsavan
4
Department of Biology, Faculty of Basic Sciences, Mashhad Branch, Islamic Azad University, Mashhad, Iran
LEAD_AUTHOR
Anderson F.A. Final report on the safety assessment of benzyl al
1
cohol, benzoic acid, and sodium benzoate. Int. J. Toxicol 2001; 20:23-50.
2
2. Yu H, Hsieh P, Chang Y, Chung P, Kuo L, Hwang T. DSM-RX78, a new phosphodiesterase inhibitor, suppresses superoxide anion production in activated human neutrophils and attenuates hemorrhagic shock-induced lung injury in rats. Biochem. Pharm 2009 ;78 : 983–992.
3
3. de Mendonça A.J.G, Cardoso C.M.P, and Juusola P.M. Activity coefficients of sodium benzoate and potassium benzoate in water at 298.15 K. Fluid Phase Equilibria 2003;214:87-100.
4
4. Mendonça A.J.G, Vaz M.I.P.M, Mendonç, D.I.M.D. Activity coefficients in the evaluation of food preservatives. Innovat Food Sci Emerg Tech 2001; 2:175-179.
5
5. Tamaro M, Dolzani L, Monti-bragadin C, Sava G. Mutagenic activity of the dacarbazine analog p-(3, 3-dimethyl-l-triazeno) benzoic acid potassium salt in bacterial cells. Pharmacol Res Commun 1986;18: 491-501.
6
6. Mamur S, Yüzbasıog˘lu D, Ünal F, Yılmaz S. Does potassium sorbate induce genotoxic or mutagenic effects in lymphocytes? Toxicol
7
2010; 24: 790–794.
8
7. Vernole P, Caporossi D, Tedeschi B, Porfirio B, Melino G, Bonmassar E, Nicoletti B. Cytogenetic effects of 1-p-(3-methyltriazeno)
9
benzoic acid potassium salt on human lymphocytes
10
. Mutat. Res.–Genetic Toxicol. Environ. Mutagen 1987;189: 349-356.
11
8. Vernole P, Caporossi D, Tedeschi B, Melino G, Porfirio B, Bonmassar E, Nicoletti B. Sister-chromatid exchanges in human lymphocytes exposed to 1-p-(3-methyltriazeno) benzoic acid potassium salt. Mutat Res Lett 1988; 208: 233-236.
12
9. Yılmaz S U.n.F, Yu¨zbas D. Clastogenic effects of food additive citric acid in human peripheral lymphocytes. Cytotechnol 2008; 56: 137–144.
13
10. Mpountoukas P, Vantarakis A, Sivridis E, Lialiaris T. Cytogenetic study in cultured human lymphocytes treated with three commonly used preservatives. Food Chem. Toxicol 2008; 46: 2390- 2393.
14
11. Ylmaz S, Ünal F, Yüzba o lu D. The
15
of benzoic acid in human peripheral blood lymphocytes. Cytotechnol 2009; 60: 55-61.
16
12. Ragge N, Brown A, Poloschek C, Lorenz B, Henderson A, Clarke M. Heterozygous Mutations of OTX2 Cause Severe Ocular Malformations. Am J Hum Genet 2005 : 76(6): 1008–1022.
17
13. Fujitani T. Short-term effect of sodium benzoate in F344 rats and B6C3F1 mice. Toxicol Lett 1993; 69: 171-179.
18
14. Berman I. Color atlas of basic histology. McGraw-Hill Medical 2003.
19
15. Afshar M, Moallem SA, Mohammadpour A, Shiravi A, Jalalian SM, Golalipour M. Teratogenic effects of carbamazepine on embryonic eye development in pregnant mice. Cutan Ocul Toxicol 2010; 29(1): 10–15.
20
16. Hrubec T, Yan M, Ye K, Salafia C, Holladay S. Valproic Acid Induced Fetal Malformations Are Reduced by Maternal Immune Stimulation with Granulocyte-Macrophage Colony-Stimulating Factor or Interferon γ. Anat Rec A Discov Mol Cell Evol Biol. 2006 ; 288(12): 1303–1309.
21
17. Calzolari E, Calabrese O, Cocchi G. Anophthalmia and situs viscerum inversus in an infant exposed to vigabatrin. Teratol 1997;56:397.
22
18. Da Costa M, Sharon M. The synthesis of folate binding protein in lymphpcytes during transformation. BJH 1980; 46:575–579.
23
19. Hanson M. The Genetics of Childhood Disease and Development:A Series of Review Articles. IPRF 2003;54(6): 791-794.
24
20. Jordan T, Hanson I, Zaletayev D, Hodgson S, Prosser J, Seawright A,
25
.The human PAX6 gene is mutated in two patients with aniridia. Nature Genetic 1992;1:328–332.
26
21. Pichaud F, Desplan C. Pax genes and eye organogenesis. Curr Opin Genet Dev2002; 12:430–434.
27
22. Thaung C, West K, Clark BJ, McKie L, Morgan JE,
28
. Novel ENU-induced eye mutationsn in the mouse: models for human eye disease . Hum Mol Genet 2002; 11:755–767.
29
23. Baulmann DC, Ohlmann A, Flugel-Koch C, Goswami S, Cvekl A, Tamm ER. Pax6 heterozygous eyes show defects in chamber angle differentiation that are associated with a wide spectrum of other anterior eye segment abnormalities. Mech Dev 2002; 118:3–17.
30
24. Tsay H.J, Wang, Y.H, Chen W.L, Huang M.Y, Chen Y.H. Treatment with sodium benzoate leads to malformation of zebra fish larvae.Neurotoxicol Teratol 2007; 29: 562-569.
31
25. Chen Y.H, Chen W.L, Wang Y.H, Huang M.Y, Chern M.K. Spatiotemporal expression of zebrafish D-amino acid oxidase during early embryogenesis. Fish Physiol Biochem 2007; 33:73-80.
32
26. Nair B. Final report on the safety assessment of benzaldehyde. Int. J. Toxicol 2006; 25:11-27.
33
27. Hierholzer C, Billiar T.R. Molecular mechanisms in the early phase of hemorrhagic shock. Langenbecks Arch. Surg 2001; 386: 302-308.
34
28. Hierholzer C, Menezes JM. Essential role of induced nitric oxide in the initiation of the inflammatory response following hemorrhagic shock. J. Exp. Med 1998; 187: 917–928.
35
29. Prater M, Zimmerman K, Pinn L, Keay J, Laudermilch C, Holladay S. Role of maternal dietary antioxidant supplementation in murine placental and fetal limb development. Placenta 2006;27: 502-509.
36
30. Horal M, Zhang Z, Stanton R, Virkamäki A, and Loeken M.R. Activation of the hexosamine pathway causes oxidative stress and abnormal embryo gene expression: Involvement in diabetic teratogenesis. Birth Defects Res. Part A Clin. Mol. Teratol 2004;70:519-527.
37
31. Bianchi P, Seguelas M.H, Parini, A, Cambon C. Activation of pro-apoptotic cascade by dopamine in renal epithelial cells is fully dependent on hydrogen peroxide generation by monoamine oxidases. Clin J Am Soc Nephrol 2003; 14: 855.
38
32. Panduri V, Weitzman S.A, Chandel N.S, Kamp D.W. Mitochondrial-derived free radicals mediate asbestos-induced alveolar epithelial cell apoptosis. Am J Physiol Lung Cell Mol Physiol 2004; 286: L1220.
39
33. Mandel D, Littner Y, Mimouni F, StavarovskyZ, Dollberg S. Increased serum potassium and intraventricular hemorrhage revisited. IMAJ 2004; 6:91.
40
34. Kluckow M, Evans N. Low systemic blood flow and hyperkalemia in preterm infants*
41
. J. Pediatr 2001; 139: 227-232.
42
35. Minor J, Becker B. A comparison of the teratogenic properties of sodium salicylate, sodium benzoate, and phenol. Toxicol Appl Pharmacol 1971; 19: 373.
43
ORIGINAL_ARTICLE
Mouse Oocytes and Embryos Cryotop-vitrification Using Low
Concentrated Solutions: Effects on Meiotic Spindle, Genetic Material
Array and Developmental Ability
https://ijbms.mums.ac.ir/article_718_fc8a358270b59d259f6cdda6448d3d53.pdf
2013-04-01
599
609
10.22038/ijbms.2013.718
Keywords:
Cryotop
Dimethylsulphoxide
Embryo
Ethyleneglycol
Immunocytochemistry
Mouse
Oocytes
Vitrification
Sahar
Almasi-turk
s.almasi@bpums.ac.ir
1
Anatomy and Cell Biology Department, Bushehr University of Medical Sciences and Health Services, Bushehr, Iran
2 Molecular and Cellular Biology Research Centre, Shaheed Beheshti University of Medical Sciences and Health Services, Tehran, Iran
AUTHOR
Amrollah
Roozbehi
2
Molecular and Cellular Biology Research Centre, Shaheed Beheshti University of Medical Sciences and Health Services, Tehran, Iran
3 Anatomy and Cell Biology Department, Yasuj University of Medical Sciences and Health Services, Yasuj, Iran
LEAD_AUTHOR
Tucker M, Morton P, Liebermann J. Human oocyte cryopreserva
1
tion: a valid alternative to embryo cryopreservation?. Obstet Gynecol 2004; 113S:S24-S27.
2
2. Kim ChG, Yong H, Lee G, Cho J. Effect of the polyvinylpyrrolidone concentration of cryoprotectant on mouse embryo development and production of pups: 7.5% of PVP is beneficial for
3
In Vitro and In Vivo
4
development of frozen-thawed mouse embryos. J Reprod Dev 2008; 54:250-253.
5
3. Sheehan CB, Lane M, Gardner DK. The cryoloop facilitates re-vitrification of embryos at four successive stages of development without impairing embryo growth. Hum Reprod 2006; 1:1-7.
6
4. Ciotti PM, Porcu E, Notarangelo L, Magrini O, Bazzocchi A, Venturoli S. Meiotic spindle recovery is faster in vitrification of human oocytes compared to slow freezing. Fertil Steril 2008; 91:2399- 2407.
7
5. Elder K, Dale B.
8
fertilization. United Kingdom: Cambridge university press; 2003.
9
6. Makarevich AV, Chrenek P, Olexikova L, Popelkova M, Turanova Z, Ostro A,
10
. Post-thaw survival, cell death and actin cytoskeleton in gene-microinjected rabbit embryos after vitrification. Theriogenology 2008; 70:675-681.
11
7. Almasi-turk S, Roozbehi A, Aliabadi E, Sadeghi Y, Haeri A, Hosseini A. Developmental consequences of mouse cryotop-vitrified oocyte and embryo using low concentrated CPAs. Iran J Reprod Med 2009; 7:181-188.
12
8. Eroglu A, Lawitts JA, Toner M, Toth TL. Quantitative microinjection of trehalose into mouse oocytes and zygotes, and its effect on development. Cryobiology 2003; 46:121-134.
13
9. Eroglu A, Bailey SE, Toner M, Toth TL. Successful cryopreservation of mouse oocytes by using low concentrations of trehalose and dimethylsulfoxide. Biol Reprod 2009; 80:70-78.
14
10. Kyono K, Nakajo Y, Kumagai S, Nishinaka C. Vitrifying and warming of oocytes using cryotop, In: Tucker MJ, Liebermann J, editors. Vitrification in assisted reproduction: A user’s manual and trouble shooting guide. United Kingdom: Informa healthcare; 2007. p. 153-161.
15
11. Soleimani R, Van der Elst J, Heytens E, Van den Broecke R, Gerris J, Dhont M,
16
Back muscle as a promising site for ovarian tissue transplantation, an animal model. Hum Reprod 2008; 23:619-626.
17
12. Balaban B, Urman B, Alatas C, Mercan R, Mumcu A, Isiklar A. A comparison of four different techniques of assisted hatching. Hum Reprod 2002; 17:1239-1243.
18
13. Zenzes MT, Bielecki R, casper RF, Leibo SP. Effects of chilling to 0°C on the morphology of meiotic spindles in human metaphase II oocytes. Fertil Steril 2001; 75:769-777.
19
14. Kuwayama M. Highly efficient vitrification for cryopreservation of human oocytes and embryos: The Cryotop method. Theriogenology 2007; 67:73-80.
20
15. Gardner DK, Weissman A, Howless CM, Shoham Z.Text book of assisted reproductive techniques: Laboratory and clinical perspectives. United Kingdom: Taylor & Francis; 2004.
21
16. Tucker MJ, Liebermann J. Vitrification in assisted reproduction: A user’s manual and trouble shooting guide, United Kingdom: Informa healthcare; 2007.
22
17. Yamada C, Caetano HVA, Simoes R, Nicacio AC, Feitosa WB, Assumpcao MEOD. Improved bovine oocyte cryopreservation: Comparison of different associations with ethylene glycol, glycerol and dimethylsulfoxide. Anim Reprod Sci 2007; 99:384-388.
23
18. Endoh K, Mochida K, Ogonuki N, Ohkawa M, Shinmen A, Ito M,
24
The developmental ability of vitrified oocytes from different mouse strains assessed by parthenogenetic activation and intaracytoplasmic sperm injection. J Reprod Dev 2007; 53:1119-1206.
25
19. Kartberg AJ, Hambiliki F, Arvidsson T, Stravreus-Evers A, Svalander P. Vitrification with DMSO protects embryo membrane integrity better than solutions without DMSO. Reprod Biomed Online 2008; 17:378-384.
26
20. Manjunatha BM, Gupta PSP, Ravindra JP, Devaraj M, Nandi S. Effect of vitrification medium composition and exposure time on post-thaw development of buffalo embryos produced
27
Vet J 2009; 179: 287-291.
28
21. Cobo A, Kuwayamam M, Perezm S, Ruiz A, Pellicer A, Remohi J. Comparison of concomitant outcome achieved with fresh and cryopreserved donor oocytes vitrified by the cryotop method. Fertil Steril 2008; 89:1657-1664.
29
22. Kuwayama M, Vajta G, Kato O, Leibo SP. Highly efficient vitrification method for cryopreservation of human oocytes. Reprod Biomed Online 2005; 11:300–308.
30
23. Katayama KP, Stehlik J, Kuwayama M, Kato O, Stehlik E. High survival rate of vitrified human oocytes results in clinical pregnancy. Fertil Steril 2003; 80:223–224.
31
24. Morato R, Izquierdo D, Paramio MT, Mogas T. Cryotops versus open-pulled straws (OPS) as carriers for the cryopreservation of bovine oocytes: Effects on spindle and chromosome configuration and embryo development. Cryobiology 2008; 57:137-141.
32
25. Songsasen N, Yu IIJ, Ratterree MS, Vandevoort CA, Leibo SP. Effect of chilling on the organization of tubulin and chromosomes in rhesus monkey oocytes. Fertil Steril 2002; 77:818-825.
33
26. Mandelbaum J, Anastasiou O, Levy R, Guerin JF, Larouziere V, Antoine JM. Effects of cryopreservation on the meiotic spindle of human oocytes. Obstet Gynecol 2004; 113S:S17-S23.
34
27. Nagai S, Mabuchi T, Hirata S, Shoda T, Kasai T, Yokota S. Correlation of abnormal mitochondria distribution in mouse oocytes with reduced developmental competence. Tohoku J Exp Med 2004; 210:137-144.
35
28. Bettencourt EMV, Bettencourt CM, Silva JNCE, Ferreira P, Matos CP, Oliveira E,
36
. Ultrastructural characterization of fresh and cryopreservaed in vivo produced ovine embryos. Theriogenology 2009; 71:947-958.
37
29. Bromfield JJ, Coticchio G, Hutt K, Sciajno R, Borini A, Albertini DF. Meiotic spindle dynamics in human oocytes following slow-cooling cryopreservation. Hum Reprod 2009; 24:2114-2123.
38
30. Zhou GB, Li N. Cryopresrvation of porcine oocytes: recent advances. Mol Hum Reprod 2009; 15:279-285.
39
31. Mullen SF, Rosenbaum M, Critser JK. The effect of osmotic stress on the cell volume, metaphase II spindle and developmental potential of
40
matured porcine oocytes. Cryobiology 2007; 54:281-289.
41
32. Shi WQ, Zhu SE, Zhang D, Wang WH, Tang GL, Hou YP
42
. Improved development by taxol pretreatment after vitrification of in vitro matured porcine oocytes. Reproduction 2006; 131:795-804.
43
33. Tharasanit T, Colenbrander B, Stout TAE. Effect of cryopreservation on the cellular integrity of equine embryos. Reprod Online 2005; 129:789-798.
44
34. Kim NH, Chung KS, Day N. The distribution and requirements of microtubules and microfilaments during fertilization and parthenogenesis in pig oocytes. J Reprod Fertil 1997; 111:143-149.
45
35. Paynter SJ. Current status of the cryopreservation of human unfertilized oocytes. Hum Reprod Update 2000; 6:449-456.
46
36. Isachenko EF, Nayudu PL. Vitrification of mouse germinal vesicle oocytes: effect of treatment temperature and egg yolk on chromatin and spindle normality and cumulus integrity. Hum Reprod 1997; 14:400-408.
47
37. Katayama M Zhongm Zh, Lai L, Sutovsky P, Prather RS, Schatten H. Mitochondrial distribution and microtubule organization in fertilized and cloned porcine embryos: implications for develop
48
mental potential. Dev Biol 2006; 299:206-220.
49
38. Vajta G, Kuwayama M, Vanderzwalmen P. Disadvantages and benefits of vitrification, In: MJ Tucker, J Libermann J, editors. Vitrification in assisted reproduction. London: Informa Healthcare; 2007. p. 33-44.
50
39. Braga DPAF, Figueira RCS, Rodrigues D, Madaschi C, Pasqualotto FF, Iaconelli A, Borges E. Prognostic value of meiotic spindle imaging on fertilization rate and embryo development in
51
-matured human oocytes. Fertil Steril 2008; 90:429-433.
52
40. Lowther KM, Weitzman VN, Maier D, Mehlmann LM. Maturation, fertilization, and the structure and function of the endoplasmic reticulum in cryopreserved mouse oocytes. Biol Reprod 2009; 81:147-154.
53
41. Gomes CM, Silva CASE, Acevedo N, Baracat E, Serafini P, Smith GD. Influence of vitirification on mouse metaphase II oocyte spindle dynamics and chromatin alignment. Fertil Steril 2008; 90:1396- 1404.
54
42. Amir A, Zvi R. Do chilling injury and heat stress share the same mechanism of injury in oocytes?. MCE 2008; 282:150-152.
55
43. Stachecki JJ, Cohen J, Schimmel T, Willadson SM. Fetal development of mouse oocytes and zygotes cryopreserved in a nonconventional freezing medium. Cryobiology 2002; 44:5-13.
56
44. Arav A, Yavin S. Measurement of essential physical properties of vitrification solutions. Theriogenology 2007; 67:81-89.
57
45. Pegg DE. Principles of Cryopreservation. Cryopreservation and freeze-drying protocols. In: JG Day, GN Stacey, editors. Methods in molecular biology. USA: Humana press Inc; 2006. p. 39-57.
58
46. Gardner DK, Sheehan CB, Rienzi L, Katz-jaffe M, Larman MG. Analysis of oocyte physiology to improve cryopreservation procedures. Theriogenology 2007; 67:64-72.
59
47. Wang WH, Meng L, Hackett RJ, Odenbourg R, Keefe DL. The spindle observation and its relationship with fertilization after intracytoplasmic sperm injection in living human oocytes. Fertil Steril 2001; 75:348-353.
60
48. Skidmore JA, Schovers E, Stout TAE. Effect of different methods of cryopreservation on the cytoskeletal integrity of dromedary camel (Camelus dromedaritus) embryos. Anim Reprod Sci 2008; 113:196-204.
61
49. Rienzi L, Martinez F, Ubaldi F, Minasi MG, Lacobelli M, tesarik J,
62
Polscope analysis of meiotic spindle changes in living metaphase II human oocytes during the freezing and thawing procedures. Hum Reprod 2004; 19:655-659.
63
50. Schroeder AC, Champlin AK, Mobraaten LE, Eppig JJ. Developmental capacity of mouse oocytes cryopreserved before and after maturation
64
J Reprod Fertil 1990; 89:43–50.
65
51. Zhang J, Nedambale TL, Yang M, Li J. Improved development of ovine matured oocyte following solid surface vitrification (SSV): Effect of cumulus cells and cytoskeleton stabilizer. Anim Reprod Sci 2009; 110:46-55.
66
52. Wang HY, Lu SS, Lun ZR. Glass transition behavior of the vitrification solutions containing propanediol, dimethyl sulfoxide and polyvinyl alcohol. Cryobiology 2009; 58:115-117.
67
53. Eroglu A, Toner M, Toth TL. Beneficial effect of microinjected trehalose on the cryosurvival of human oocytes. Fertil Steril 2002; 77:152-158.
68
54. Stachecki JJ, Cohen J, Willadsoen S. Cryopreservation of unfertilized mouse oocytes: The effect of replacing sodium with choline in the freezing medium. Cryobiology 1998; 37:346-354.
69
55. Stachecki JJ, Cohen J, Willadsen S. Detrimental effects of sodium during mouse oocyte cryopreservation. Biol Rerod 1998; 59:395- 400.
70
56. Larman MK, Sheehan CB, Gardner DK. Calcium-free vitrification reduces cryoprotectant-induced zona pellucida hardening and increases fertilization rates in mouse oocytes. Reproduction 2006; 131:53-61.
71
57. Chian RC, Kuwayama M, Tan L, Tan J, Kato O, Nagai T. High survival rate of bovine oocytes matured in vitro following vitrification. J Reprod Dev 2004; 50:685-696.
72
58. Rupert-Lingham CJ, Paynter SJ, Godfrey J, Fuller BJ, Shaw RW. Developmental potential of murine germinal vesicle stage cumulus-oocyte complexes following exposure to dimethylsulphoxide or cryopreservation: Loss of membrane integrity of cumulus cells after thawing. Hum Reprod 2003; 18:392-398.
73
59. VandeVoort CA, Shirley CR, Hill DL, Leibo SP. Effects of CPAs and cryopreservation on germinal vesicle-stage cumulus-oocyte complexes of rhesus monkeys. Fertil Steril 2008; 90:805-816.
74
ORIGINAL_ARTICLE
Inter-individual Variability of Coumarin 7-hydroxylation (CYP2A6
activity) in an Iranian Population
https://ijbms.mums.ac.ir/article_719_9928866b64c9d4e7717e8689e92126f2.pdf
2013-04-01
610
614
10.22038/ijbms.2013.719
Keywords:
CYP2A6
Coumarin
Fluorometry
Iran
Polymorphism
7-hydroxycoumarin
Mohammad
Hassanzadeh Khayyat
1
Drug research center, Faculty of Pharmacy, Mashhad University of Medical Sciences, Mashhad, 91775-1365, Iran
AUTHOR
Nasser
Vahdati-Mashhadian
2
Medical Toxicology Research Centre, Faculty of Medicine and Department of Pharmacodynamy and Toxicology, Faculty of Pharmacy, Mashhad University
LEAD_AUTHOR
Saeed
Eghbal
3
Drug research center, Faculty of Pharmacy, Mashhad University of Medical Sciences, Mashhad, 91775-1365, Iran
AUTHOR
Navid
Jalali
4
Drug research center, Faculty of Pharmacy, Mashhad University of Medical Sciences, Mashhad, 91775-1365, Iran
AUTHOR
Ingelman-Sundberg M, Oscarson M, McLellan RA. Polymorphic
1
human cytochrome P450 enzymes: an opportunity for individualized drug treatment. Trends Pharmacol Sci 1999; 20:342-349.
2
2. Schneider E, Clark DS. Cytochrome P450 (CYP) enzymes and the development of CYP biosensors. Biosens Bioelectron 2013; 39:1-13.
3
3. Singh D, Kashyap A, Ram Vinay Pandey RV, Saini KS. Novel advances in cytochrome P450 research. Drug Discov Today 2011; 16:793-799.
4
4. Le Gal A, Dreano Y, Lucas D, Berthou F. Diversity of selective environmental substrates for human cytochrome P450 2A6: alkoxyethers, nicotine, coumarin, N-nitrosodiethylamine, and N-nitrosobenzylmethylamine. Toxicol Lett 2003; 144:77-91.
5
5. Miles JS, McLaren AW, Forrester LM, Glancey MJ, Lang MA, Wolf CR. Identification of the human liver cytochrome P-450 responsible for coumarin 7-hydroxylase activity. Biochem J 1990; 267:365–371.
6
6. Yamano S, Tatsuno J, Gonzalez FJ. The CYP2A3 gene product catalyzes coumarin 7-hydroxylation in human liver microsomes. Biochemistry 1990; 29:1322-1329.
7
7. Koskela S, Hakkola J, Hukkanen J, Pelkonen O, Sorri M, Saranen A,
8
. Expression of CYP2A genes in human liver and extrahepatic tissues. Biochem Pharmacol 1999; 57:1407-1413.
9
8. Oscarson M. Genetic polymorphisms in the cytochrome p450 2a6 (cyp2a6) gene: implications for interindividual differences in nicotine metabolism. Drug Metab Dispos 2001; 29:91-95.
10
9. Lake BG. Coumarin metabolism, toxicity and carcinogenicity: relevance for human risk assessment. Food Chem Toxicol 1999; 37:423-453.
11
10. Thornes D, Daly L, Lynch G, Browne H, Tanner A, Keane F
12
Prevention of early recurrence of high risk malignant melanoma by coumarin. Irish Melanoma Group. Eur J Surg Oncol 1989; 15:431-435.
13
11. Dexeus FH, Logothetis CJ, Sella A, Fitz K, Amato R, Reuben JM,
14
Phase II study of coumarin and cimetidine in patients with metastatic renal cell carcinoma. J Clin Oncol 1990; 8:325-329.
15
12. Gal A, Dre´ano Y,Lucas D, Berthou F. Diversity of selective environmental substrates for human cytochrome P450 2A6: alkoxyethers, nicotine, coumarin, N-nitrosodiethylamine, and N-nitrosobenzylmethylamine. Toxicol Lett 2003; 144:77-91.
16
13. Higashi E, Nakajima M, Katoh M, Tokudome S, Yokoi T. Inhibitory effects of neurotransmitters and steroids on human CYP2A6. Drug Metab Dispos 2007; 35:508-514.
17
14. Xu C, Goodz S, Sellers EM, Tyndale RF. CYP2A6 genetic variation and potential consequences. Adv Drug Deliv Rev 2002; 54:1245–1256.
18
15. Kim D, Wu ZL, Guengerich FP. Analysis of coumarin 7-hydroxylation activity of cytochrome P450 2A6 using random mutagenesis. J Biol Chem 2005; 280:40319-40327.
19
16. Pelkonen O, Rautio A, Raunio H, Pasanen M. CYP2A6: a human coumarin 7-hydroxylase. Toxicology 2000; 144:139–147.
20
17. Rautio A, Kraul H, Kojo A, Salmela E, Pelkonen O. Interindividual variability of coumarin 7-hydroxylation in healthy volunteers. Pharmacogenetics 1992; 2:227-233.
21
18. Rauma AL, Rautio A, Pasanen M, Pelkonen O, Torronen R, Mykkanen H. Coumarin 7-hydroxylation in long-term adherents of a strict uncooked vegan diet. Eur J Clin Pharmacol 1996; 50:133-137.
22
19. Ritschel WA, Brady ME, Tan HS, Hoffmann KA, Yiu IM, Grummich KW. Pharmacokinetics of coumarin and its 7-hydroxy-metabolites upon intravenous and peroral administration of coumarin in man. Eur J Clin Pharmacol 1977; 12:457-461.
23
20. Emamghoreishi M, Bokaee HR, Keshavarz M, Ghaderi A, Tyndale RF. CYP2A6 Allele Frequencies in an Iranian population. Arch Iran Med 2008; 11:613 – 617.
24
21. Iscan M, Rostami H, Iscan M, Guray T, Pelkonen O, Rautio A. Interindividual variability of coumarin 7-hydroxylation in a Turkish population. Eur J Clin Pharmacol 1994; 47: 315-318.
25
22. Xu P, Huang SL, Xu RH, Han XM, Zhou HH. Phenotypic polymorphism of CYP2A6 activity in a Chinese population. Eur J Clin Pharmacol 2002; 58:333-337.
26
23. Afshar M, Rouini M, Ala S. Dextromethorphan metabolic phenotyping in an Iranian population. Eur J Clin Pharmacol 2005; 60:849-854.
27
24. Kouhi H, Hamzeiy H, Bara J, Asadi M, Omidi Y. Frequency of five important CYP2D6 alleles within an Iranian population (Eastern Azerbaijan). Gnet Test Mol Biomarkers 2009; 13:665-670.
28
ORIGINAL_ARTICLE
The Effect of Carvacrol on Serum Cytokines and Endothelin Levels of Ovalbumin Sensitized Guinea-Pigs
https://ijbms.mums.ac.ir/article_720_7e095ca732c8ca2c59046075870ec571.pdf
2013-04-01
615
619
10.22038/ijbms.2013.720
Keywords:
Asthma
Carvacrol
Cytokines
Dexamethasone
Sensitization
Sediqeh
Jalali
1
Department of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran
LEAD_AUTHOR
Mohammad Hossein
Boskabady
boskabadymh@mums.ac.ir
2
1 Neurogenic Inflammation Research Centre and Department of Physiology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
AUTHOR
Ali
Haeri-Rohani
3
Department of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran
AUTHOR
Akram
Eidi
4
Department of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran
AUTHOR
Dexamethasone
1
Sensitization
2
ORIGINAL_ARTICLE
Screening, Cloning and Expression of Active Streptokinase from an
Iranian Isolate of S.equisimilis Group C in E. coli
https://ijbms.mums.ac.ir/article_721_5196115580fe51cbcac3a16210507931.pdf
2013-04-01
620
627
10.22038/ijbms.2013.721
Keywords:
Gene expression
Recombinant streptokinase
Streptococcus
Malihe
Keramati
1
Microbiology Department, Pasteur Institute of Iran, Tehran, Iran
AUTHOR
Farzin
Roohvand
2
Virology Department, Pasteur Institute of Iran, Tehran, Iran
AUTHOR
Mohammad Mehdi
Aslani
mmaslani@yahoo.com
3
Microbiology Department, Pasteur Institute of Iran, Tehran, Iran
AUTHOR
Shohreh
Khatami
4
Biochemistry Department, Pasteur Institute of Iran, Tehran, Iran
AUTHOR
Mohammad reza
Aghasadeghi
5
Hepatitis and AIDS Department, Pasteur Institute of Iran, Tehran, Iran
AUTHOR
Mehdi
Sadat
6
Hepatitis and AIDS Department, Pasteur Institute of Iran, Tehran, Iran
AUTHOR
Arash
Memarnejadian
7
Hepatitis and AIDS Department, Pasteur Institute of Iran, Tehran, Iran
AUTHOR
Fatemeh
Motevalli
8
Hepatitis and AIDS Department, Pasteur Institute of Iran, Tehran, Iran
AUTHOR
Anmol Kumar AK, KK Pulicherla KKP, K. Seetha Ram KSR, KRS Sam
1
basiva Rao KRSSR. Evolutionary trend of thrombolytics. Int J Bio Sci Bio Technol 2010; 2:51-68.
2
2. Banerjee A, Chisti Y, Banerjee UC. Streptokinase--a clinically useful thrombolytic agent. Biotechnol Adv 2004; 22:287-307.
3
3. Kunamneni A, Abdelghani TTA, Ellaiah P. Streptokinase—the drug of choice for thrombolytic therapy. J Thromb Thrombolysis. 2007; 23:9-23.
4
4. Baruah DB, Dash RN, Chaudhari M, Kadam S. Plasminogen activators: A comparison. Vasc Pharmacol 2006; 44:1-9.
5
5. Della G, Miocardico SNI. GISSI-2: a factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12,490 patients with acute myocardial infarction. Lancet 1990; 336:65-71.
6
6. Ridker PM, O’Donnell C, Marder VJ, Hennekens CH. Large-scale trials of thrombolytic therapy for acute myocardial infarction: GISSI-2, ISIS-3, and GUSTO-1. Ann Int Med 1993; 119:530.
7
7. Sikri N, Bardia A. A history of streptokinase use in acute myocardial infarction. Texas Heart Institute J 2007; 34:318-327.
8
8. Abdelghani TTA, Kunamneni A, Ellaiah P. Isolation and mutagenesis of streptokinase producing bacteria. Am J Immunol 2005; 1:125-129.
9
9. Arabi R, Roohvand F, Noruzian D, sardari S, Aghasadeghi MR, Khanamad H,
10
. A comparative study on the activity and antigenicity of truncated and full-length forms of streptokinase. Polish J Microbiol 2011; 60:243-252.
11
10. Malke H. Polymorphism of the streptokinase gene: implications for the pathogenesis of post-streptococcal glomerulonephritis. Zentralblatt für Bakteriologie. Int J Med Microbiol 1993; 278:246- 253.
12
11. Malke H, Steiner K, Gase K, Mechold U, Ellinger T. The streptokinase gene: allelic variation, genomic environment and expression control. Dev Biol Stand 1995; 85:183.
13
12. Pupo E, Baghbaderani BA, Lugo V, Fernández J, Páez R, Torréns I. Two streptokinase genes are expressed with different solubility in Escherichia coli W3110. Biotechnol lett 1999; 21:1119-1123.
14
13. Keramati M, Roohvand F, Eslaminejad Z, Nikbin VS, Aslani MM. PCR/RFLP-based allelic variants of streptokinase and their plasminogen activation potencies. FEMS Microbiol Lett 2012; 335:79- 85.
15
14. Tewodros W, Norgren M, Kronvall G. Streptokinase activity among group A streptococci in relation to streptokinase genotype, plasminogen binding, and disease manifestations. Microbial Pathogenesis 1995; 18:53-65.
16
15. Al Sohaimy S, Aleem E, Hafez EE, Esmail SS, El-Saadani M, Moneim NA. Expression of recombinant Streptokinase from local Egyptian Streptococcus sp. SalMarEg. Afr J Biotechnol 2011; 105:9001- 9011.
17
16. Freeda F. Production and partial purification of streptokinase by streptococcus sp. Int J Students Project (IJSP)-Biotechnol 2010; 1:1-39.
18
17. Doss HM, Manohar M, Singh NA, Mohanasrinivasan V, Devi CS. Studies on isolation, screening and strain improvement of streptokinase producing -hemolytic streptococci. World J Sci Technol 2011; 1:7-11.
19
18. Garrity GM, Brenner DJ, Krieg NR. Bergey’s manual of systematic bacteriology. Springer; 2005.
20
19. Kim DM, Lee SJ, Kim IC, Kim ST, Byun SM. Asp41-His48 region of streptokinase is important in binding to a substrate plasminogen. Thrombosis Res 2000; 99:93-98.
21
20. Sambrook J, Russell DW. The condensed protocols from molecular cloning: a laboratory manual: Cold Spring Harbor Laboratory
22
Pr; 2006; 8.
23
21. Crowe J, Henco K. The QIAexpressionist. DIAGEN GmbH, Hilden, Germany: 1992.p.2.
24
22. Ingham KC. Precipitation of proteins with polyethylene glycol. Methods Enzymol 1990; 182:301-306.
25
23. Wohl RC, Summaria L, Robbins K. Kinetics of activation of human plasminogen by different activator species at pH 7.4 and 37 degrees C. J Biologic Chem 1980; 255:2005-2011.
26
24. Wu XC, Ye R, Duan Y, Wong SL. Engineering of plasmin-resistant forms of streptokinase and their production in Bacillus subtilis: streptokinase with longer functional half-life. App Environ Mi�crobiol 1998; 64:824-830.
27
25. Pimienta E, Ayala JC, Rodríguez C, Ramos A, Van Mellaert L, Vallín C,
28
. Recombinant production of Streptococcus equisimilis streptokinase by Streptomyces lividans. Microb Cell Fact 2007; 6:20-31.
29
26. Sands D, Whitton C, Longstaff C. International collaborative study to establish the 3rd International Standard for Streptokinase. J Thromb Haemost 2004; 2:1411-1415.
30
27. Winn WC, Koneman EW. Koneman’s color atlas and textbook of diagnostic microbiology. Lippincott williams & wilkins; 2006.
31
28. Hughes JM, Wilson ME, Brandt CM, Spellerberg B. Human infections due to Streptococcus dysgalactiae subspecies equisimilis. Clin Infect Dis 2009; 49:766-772.
32
29. Barnham M, Kerby J, Chandler R, Millar M. Group C streptococci in human infection: a study of 308 isolates with clinical correlations. Epidemiol Infect 1989; 102:379-390.
33
30. Davies MR, McMillan DJ, Sriprakash KS, Chhatwal GS. Distribution of group A streptococcal virulence genes in group C and G streptococci. Int Cong Series 2006; 1289:184-187.
34
31. Steiner K, Malke H. Dual control of streptokinase and streptolysin S production by the covRS and fasCAX two-component regulators in Streptococcus dysgalactiae subsp. equisimilis. InfectImmun. 2002; 70:3627-3636.
35
32. Kim MR, Choeng YH, Chi WJ, Kang DK, Hong SK. Heterologous production of streptokinase in secretory form in streptomyces lividans and in nonsecretory form in escherichia coli. J Microbiol Biotechnol 2010; 20:132-137.
36
33. Balagurunathan B, Ramchandra NS, Jayaraman G. Enhancement of stability of recombinant streptokinase by intracellular expression and single step purification by hydrophobic interaction chromatography. Biochem Engineering Journal. 2008;39(1):84- 90.
37
34. Longstaff C, Thelwell C, Whitton C. The poor quality of streptokinase products in use in developing countries. J Thromb Haemost 2005; 3:1092-1094.
38
ORIGINAL_ARTICLE
Single and Concurrent Effects of Endurance and Resistance Training on
Pulmonary Function
https://ijbms.mums.ac.ir/article_722_6ab7a3326e4caa64de11afd066c747cf.pdf
2013-04-01
628
634
10.22038/ijbms.2013.722
Keywords:
Endurance and Resistance Training
FEV1
FVC
MVV
PEF
VC
Maryam
Khosravi
1
Exercise Physiology Division, Faculty of Physical Education and Sport Science, Islamic Azad University-Ayatollah Amoli Branch, Amol, Mazandaran, Iran
AUTHOR
Seyed Morteza
Tayebi
tayebism@gmail.com
2
Exercise Physiology Division, Faculty of Physical Education and Sport Science, Islamic Azad University-Ayatollah Amoli Branch, Amol, Mazandaran, Iran
AUTHOR
Hamed
Safari
3
Faculty of Physical Education and Sport Science, Science and Research Branch, Islamic Azad University, Hamedan, Iran
AUTHOR
ORIGINAL_ARTICLE
Co-precipitation with PVP and Agar to Improve Physicomechanical
Properties of Ibuprofen
https://ijbms.mums.ac.ir/article_723_489536186afc6f45fb5bc25acbd3bae6.pdf
2013-04-01
635
642
10.22038/ijbms.2013.723
Keywords:
Agar
Co-precipitation
Crystallization
Ibuprofen
PVP
Maryam
Maghsoodi
1
Drug applied Research Centre and School of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran
AUTHOR
Farhad
Kiafar
kiafarf@tbzmed.ac.ir
2
Drug applied Research Centre and School of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran
AUTHOR
P. Crystal engineering and particle design for the powder
1
compaction process. Drug Dev Ind Pharm 1992; 18:677-721.
2
2. York P, Shekunov Byu. Crystallization processes in pharmaceutical technology and drug delivery design. J Cryst Growth 2000; 211:122-136.
3
3. Rasenack N, Muller B. Crystal habit and tableting behavior of ibuprofen. Int J Pharm 2002a; 244:45–57.
4
4. Rasenack N, Muller B. Ibuprofen crystal with optimized properties. Int J Pharm 2002b; 245: 9–24.
5
5. Khan MA, Bolton S, Kislalioglu MS. Optimization of process variables for the preparation of Ibuprofenco-precipitates with Eudragit S100. Int J Pharm 1994; 102:185-192.
6
6. Kachrimanis K, Ktistis G, Malamataris S. Crystallization conditions and physicochemical properties of ibuprofen- Eudragit S100 spherical crystal agglomerates prepared by the solvent-change technique. Int J Pharm 1998; 173:61-74.
7
7. Pawar A, Paradkar A, Kadam Sh, Mahadik K. Agglomeration of Ibuprofenwith Talc by Novel Crystallo-Co-Agglomeration Technique. AAPS PharmSciTech 2004; 7;5:e55 .
8
8. Zimmermann A, Millqvist-Fureby A, Ringkjbing Elema M, Hansen T, Müllertz A, Hovgaard L. Adsorption of pharmaceutical excipients onto microcrystals of siramesine hydrochloride: Effects on physicochemical properties. Eur J Pharm Biopharm 2009; 71:109–116.
9
9. Li XS, Wang JX, Shen ZG, Zhang PY, Chen JF, Yun J. Preparation of uniform prednisolone microcrystals by a controlled microprecipitation method. Int J Pharm 2007; 342:26–32.
10
10. Carr RL. Classifying flow properties of solids. Chem Eng 1965; 72:69–72.
11
11. Carr RL. Evaluation flow properties of solids. Chem Eng 1965; 72:163–168.
12
12. Higuchi T, Connors KA. Phase solubility techniques. Adv Anal Chem Instr 1965; 4:117–212.
13
13. Brown S, Rowley G, Pearson JT. Surface treatment of the hydrophobic drug danazol to improve drug dissolution. Int J Pharm.1998; 165: 227–237.
14
14. Fell JT, Newton JM. Determination of tablet strength by the diametral– compression test. J Pharm Sci 1970; 59:688–691.
15
15. Tian F, Saville DJ, Gordon KC, Strachan CJ, Zeitler JA, Sandler N,
16
. The influence of various excipients on the conversion kinetics of carbamazepine polymorphs in aqueous suspension. J Pharm Pharmacol 2007; 59:193–201.
17
16. Lu GW, Smith M, Geiger BM, Pfund W. Characterization of a novel polymorphic form of celecoxib. J Pharm Sci 2006; 95:305-317.
18
17. Raghavan L, Davis AF, Hadgraft J. Crystallization of hydrocortisone acetate: influence of polymers. Int J Pharm 2001; 212:213-221.
19
18. Jain P, Banga AK. Inhibition of crystallization in drug-in-adhesive-type transdermal patches. Int J Pharm 2010; 394:68-74.
20
19. Subedi RK, Ryoob JP, Moon Ch, Choi HK. Influence of formulation variables in transdermal drug delivery system containing zolmitriptan. Int J Pharm 2011; 419:209– 214.
21
20. Yang J, Grey K, Doney J. An improved kinetics approach to describe the physical stability of amorphous solid dispersions Original Research Article. Inter J Pharm 2010; 384: 24-31.
22
21. Jbiilou M, Ettabia A, Guyot-Harmann AM, Guyot JC. Ibuprofenagglomerates preparation by phase separation. Drug Dev Ind J Pharm 1999; 25:297-305.
23
22. Tiwary AK. Modification of crystal habit and its role in dosage form performance. Drug Dev Ind Pharm 2001; 27:699-709.
24
23. Garekani HA, Sadeghi F, Badiee A, Mostafa SA, Rajabi-Siahboomi AR. Crystal Habit Modifications of Ibuprofen and their Physicomechanical Characteristics. Drug Dev Ind Pharm 2001; 27:803–809.
25
24. El-Said Y. Effect of Co-solvents on water content and physical properties of acetaminophen crystallized from aqueous solutions. STP Pharm Sci 1995; 5:232-237.
26
25. Garekani HA, Ford JL, Rubinstein MH, Rajabi- Siahboomi AR. Highly compressible paracetamol. I: Crystallization and characterization. Int J Pharm 2000; 208:87-99.
27
26. Joiris E, Di Martino P, Berneron C, Guyot-Hermann AM, Guyot JC. Compression behavior of orthorhombic paracetamol. Pharm Res 1998; 15:1122–1130.
28
27. Milosovitch G. Direct compression of tablets. Drug Cosmet Ind 1963; 5:557-569.
29
28. Nystrom C, Mazur J, Sjogren J. Studies on direct compression of tablets II. The influence of the particle size of a dry binder on the mechanical strength of tablets. Int J Pharm 1982; 10:209–218.
30
29. Duberg M, Nystrom C. Studies on direct compression of tablets XII. The consolidation and bonding properties of some pharmaceutical compounds and their mixtures with Avicel 105. Int J Pharm Tech Prod Manuf 1985; 6:17–25.
31
30. Nystrom C, Glazer M. Studies on direct compression of tablets. XIII. The effect of some dry binders on the tablet strength of compounds with different fragmentation propensity. Int J Pharm 1985; 23:255–263.
32
31. Abdel-Hamid S, Alshihabi F, Betz G. Investigating the effect of particle size and shape on high speed tableting through radial die-wall pressure monitoring. Int J Pharm 2011; 413:29-35.
33
32. Podczeck F, Al-Muti E. The tensile strength of bilayered tablets made from different grades of microcrystalline cellulose. Eur J Pharm Sci 2010; 41:483-488.
34
33. Paluch KJ, Tajber L, Adamczyk B, Corrigan OI, Healy AM. A novel approach to crystallisation of nanodispersible microparticles by spray drying for improved tabletability. Int J Pharm 2012; 436:873-876.
35
34. Nokhodchi A, Rubinstein MH, Larhrib H, Guyot JC. The effect of moisture content on the energies involved in the compaction of ibuprofen. Int J Pharm 1995; 120:13–20.
36
35. Roberts M, Ford JL, MacLeod GS, Fell JT, Smith GW,
37
. Effect of punch tip geometry and embossment on the punch tip adherence of a model Ibuprofenformulation. J Pharm Pharmacol 2004; 56: 947–950.
38
36. Ye F, Yaghmur A, Jensen H, Larsen SW, Larsen C, Østergaard J. Real-time UV imaging of drug diffusion and release from Pluronic F127 hydrogels .Eur J Pharm Sci 2011; 43:236-243.
39
37. Craig DQ. The mechanisms of drug release from solid dispersions in water-soluble polymers. Int J Pharm 2002; 231:131-144.
40
38. Smiti K, Garima C, Arvind KB. Role of additives like polymers and surfactants in the crystaliization of Mebendazol. Yakugaku Zasshi 2008; 128:281-289.
41
ORIGINAL_ARTICLE
Frequency and the Type of Chromosomal Abnormalities in Patients
with Primary Amenorrhea in Northeast of Iran
https://ijbms.mums.ac.ir/article_724_f9f8b58f8602dda40be1f07eba4508d5.pdf
2013-04-01
643
647
10.22038/ijbms.2013.724
Keywords:
Chromosomal abnormalities
Cytogenetic Study
Iran
Karyotyping
Primary Amenorrhea
Farnaz
Mohajertehran
mohajertf1@mums.ac.ir
1
Department of Genetics, Ghaem Hospital, Mashhad University of Medical Sciences , Mashhad, Iran
AUTHOR
Kazem
Ghodsi
2
Departmen of Medical Genetics and Immunology and Allergy Immunology and stem cell Department, Ghaem Hospital, Mashhad University of Medical
LEAD_AUTHOR
Leili
Hafizi
3
Obstetrics & Gynecology Department, Imam Reza Hospital, Mashhad University of Medical Sciences, Mashhad, Iran
AUTHOR
Ameneh
Rezaee
4
Urgency Department, Imam Reza Hospital, Mashhad University of Medical Sciences , Mashhad, Iran Dental Research Center, School of Dentistry, Mashhad
University of Medical Sciences, Mashhad, Iran
AUTHOR
Schorge JO, Schaffer JI, Halvorson LM, Hoffman BL, Bradshaw KD,
1
Cunningham FG. Amenorrhea. In: Schorge JO, Schaffer JI.editors. Williams Gynecology. New York, NY: McGraw Hill; 2008.p. 1112- 1128.
2
2. Speroff L, Glass RH, Kase NG. editors. Amenorrhea. In: Clinical Gynecologic Endocrinology and Infertility. 6th ed. USA: Lippincott Williams and Wilkins; 1999. p. 421-476.
3
3. Achermann J, Huges IA. Disorders of Sex Development. In: Kronenberg HM. Editor. Williams’s, Textbook of Endocrinology, 11th ed. Philadelphia: Saunders Elsevier; 2008.p. 811-822.
4
4. Rosa RF, Dibi R P, Picetti JS, Rosa RC, Zen PR, Graziadio C,
5
Amenorrhea and X chromosome abnormalities. Rev Bras Ginecol Obstet 2008; 30:511-517.
6
5. Zhao X, Shen GM, Feng Q, Sun XG, Luo Y. Cytogenetic studies of 131 patients with primary amenorrhea (including three novel abnormal karyotypes). Yi Chuan 2008; 30:996-1002.
7
6. Balkan M, Akbas H, Isi H
8
, Oral D, Turkyılmaz A, Kalkanli S, Simsek S, et al. Cytogenetic analysis of 4216 patients referred for suspected chromosomal abnormalities in Southeast Turkey. Genet Mol Res 2010; 9:1094-1103.
9
Wong MSF, Lam STS. Cytogenetic analysis of patients with primary amenorrhea and secondary amenorrhea in Hong Kong: retrospective study. Hong Kong Med J 2005; 11:267-272.
10
8. Joseph A, Thomas IM. Cytogenetic investigation in 150 cases with complaints of sterility or primary amenorrhea. Hum Genet 1982; 61:105-109.
11
9. Ten SK, Chin YM, Noor PJ, Hassan K. Cytogenetic studies in women with primary amenorrhea. Singapore Med J 1990; 31:355-359.
12
10. Temocin K, Vardar MA, Suleymanova D, Ozer E, Tanriverdi N, Demirhan O . Results of cytogenetic investigation in adolescent patients with primary or secondary amenorrhea. J Pediatr Adolesc Gynecol 1997; 10:86-88.
13
11. Roy AK, Banerjee D. Cytogenetic study of primary amenorrhoea. J Indian Med Assoc 1995; 93:291-292.
14
12. Niekerk WA. Chromosomes and the gynecologist. Am J Obstet Gynecol 1978; 130:862-875.
15
13. Safaei A, Vasei M, Ayatollahi H. Cytogenetic analysis of patients with primary amenorrhea in Southwest of Iran. Iran J Pathol 2010; 5:121-125.
16
14. Verma RS, Arvind B. Human chromosomes- principles and techniques. 2nd ed. New York: McGraw-Hill Inc; 1995.
17
15. Vijayalakshmi J, Koshy T, Kaur H. Cytogenetic analysis of patients with primary amenorrhea. Int J Hum Genet 2010; 10: 71-76.
18
16. Lakhal B, Laissue P, Braham R, Elghezal H, Saâd A, Fellous M,
19
BMP15 and premature ovarian failure: causal mutations, variants, polymorphisms? Clin Endocrinol (Oxf) 2009; 72:425–426.
20
17. Vasu VR, Chandra N, Santhiya ST. X;7 translocation in an Indian woman with hypergonadotropic amenorrhea—a case report. Genet Test Mol Biomarkers 2009; 13:533–536.
21
Cortés-Gutiérrez EI, Dávila-Rodríguez MI, Vargas- Villarreal J, Cerda-Flores RM. Prevalence of chromosomal aberrations in Mexican women with primary amenorrhoea. Reprod Biomed Online 2007; 15:463-467.
22
19. Kalavathi VN, Renjini Nambiar G, Chandra N, Jayashree S, Sugunashankari P, Meena J,
23
Chromosomal abnormalities in 979 cases of amenorrhea: a review. Int J Hum Genet 2010; 10:65–69.
24
20. Ramírez G, Herrera C, Durango N, Ramírez J. Cariotipo 45, X/46, X, r(X) en pacientes con diagnostic clínico de síndrome de Turner / 45, X/46, X, r (X) karyotype in patients with clinical diagnosis of Turner’s syndrome. Iatreia 2000; 13:161-166.
25
21. Kong H, Ge YS, Wu Q, Wu HN, Zhou DX, Shen YY. Molecular and cytogenetic study on 18 cases of amenorrhea: the use of fluorescence in situ hybridization and high resolution comparative genomic hybridization. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2007; 24:256-60.
26
22. Butnariu L, Covic M, Ivanov I, Bujoran C, Gramescu M, Vlad Gorduza E. Clinical and cytogenetic correlation in primary and secondary amenorrhea: retrospective study on 531 patients. Revista Român
27
ă de Medicină de Laborator 2011; 19:149-160.
28
ORIGINAL_ARTICLE
Effects of Postconditioning, Preconditioning and Perfusion of
L-carnitine During Whole Period of Ischemia/ Reperfusion on Cardiac
Hemodynamic Functions and Myocardial Infarction Size in Isolated
Rat Heart
https://ijbms.mums.ac.ir/article_725_fc79015db1ab719f6c3f8aea64316d42.pdf
2013-04-01
648
655
10.22038/ijbms.2013.725
Keywords:
Hemodynamic
Ischemia
L-carnitine
Postconditioning
Preconditioning
Rat
Reperfusion
Moslem
Najafi
najafimoslem@yahoo.com
1
Department of Pharmacology and Toxicology, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran
LEAD_AUTHOR
Flanagan LJ, Simmons AP, Vehige J, Willcox DPM, Garrett Q. Role
1
of carnitine in disease. Nutr Metab 2010; 7:30.
2
2. Oyanagi E, Yano H, Uchida M, Utsumi K, Sasaki J. Protective action of l-carnitine on cardiac mitochondrial function and structure against fatty acid stress. Biochem Biophys Res Commun 2011; 412: 61-67.
3
3. Şıktar E, Ekinci D, Şıktar E, Beydemir S, Gülçin I, Günay M. Protective role of L-carnitine supplementation against exhaustive exercise induced oxidative stress in rats. Eur J Pharmacol 2011; 668:407–413.
4
4. Neely JR, Morgan HE. Relationship between carbohydrate and lipid metabolism and the energy balance of heart muscle. Ann Rev Physiol 1974; 36:413-459.
5
5. Arsenian MA. Carnitine and its derivatives in cardiovascular disease. Prog Cardiovasc Dis 1997; 40:265-286.
6
6. Ferrari R, Merli E, Cicchitelli G, Mele D, Fucili A, Ceconi C. Therapeutic effects of L-carnitine on cardiovascular diseases. Ann NY Acad Sci 2004; 1033:79-91.
7
7. Calo AL, Pagnin E, Davis AP, Semplicini A, Nicolai R, Calvani M,
8
Antioxidant effect of l-carnitine and its short chain esters Relevance for the protection from oxidative stress related cardiovascular damage. Int J Cardiol 2006; 107:54-60.
9
8. Arsenian MA, New PS, Cafasso CM. Safety, tolerability, and efficacy of a glucose-insulin-potassium-magnesium-carnitine solution in acute myocardial infarction. Am J Cardiol 1996; 78:477-479.
10
9. Lopaschuk G. Regulation of carbohydrate metabolism in ischemia and reperfusion. Am Heart J 2000; 139:S115-119.
11
10. Lango R, Smolenski RT, Narkiewicz M, Suchorzewska J, Lysiak- Szydlowska W. Influence of L-carnitine and its derivatives on myocardial metabolism and function in ischemic heart disease and during cardiopulmonary bypass. Cardiovasc Res 2001; 51:21- 29.
12
11. Cui J, Das DK, Bertelli A, Tosaki A. Effects of L-carnitine and its derivatives on postischemic cardiac function, ventricular fibrillation and necrotic and apoptotic cardiomyocyte death in isolated rat hearts. Mol Cell Biochem 2003; 254:227-234.
13
12. Najafi M, Garjani A. The effect of L-carnitine on arrhythmias in the ischemic rat heart. Iran J Basic Med Sci 2005; 8:38-44.
14
13. Najafi M, Garjani A, Maleki N, Eteraf Oskouei T. Antiarrhythmic and Arrhythmogenic Effects of L-Carnitine in Ischemia and Reperfusion. Bull Exp Biol Med 2008; 146:210-21 3.
15
14. Najafi M, Javidnia A, Ghorbani-Haghjo A, Mohammadi S, Garjani A. Pharmacological Preconditioning with L-carnitine: Relevance to Myocardial Hemodynamic Function and Glycogen and Lactate Content. Pak J Pharm Sci 2010; 23: 250-255.
16
15. Najafi M, Ghaffary S, Shaseb E. Effects of Acetyl-L-Carnitine on Cardiac Arrhythmias and Infarct Size in Ischemic-Reperfused Isolated Rat Heart. Iran J Basic Med Sci 2010; 13:216-222.
17
16. Zacharowski K, Blackburn B, Thiemermann C. Ranolazine, A partial fatty acid oxidation inhibitor, reduces myocardial infarct size and cardiac troponin T release in the rat. Eur J Pharmacol 2001; 418:105-110.
18
17. Hausenloy JD, Duchen RM, Yellon MD. Inhibiting mitochondrial permeability transition pore opening at reperfusion protects against ischemia–reperfusion injury. Cardiovasc Res 2003; 60:617–625.
19
18. Yamada KA, Kanter EM, Newatia A. Long-chain acylcarnitine induces Ca
20
efflux from the sarcoplasmic reticulum. J Cardiovasc Pharmacol 2000; 36:14–21.
21
19. Clarke B, Wyatt KM, May GR, McCormack JG. On the roles of long chain acyl carnitine accumulation and impaired glucose utilization in ischemic contracture development and tissue damage in the guinea-pig heart. J Mol Cell Cardiol 1996; 28:171–181.
22
20. Wu J, Corr PB. Palmitoylcarnitine increases [Na
23
]i and initiates transient inward current in adult ventricular myocytes. Am J Physiol. 1995; 268: H2405–2417.
24
21. Haigney MCP, Lakatta EG, Stern MD, Silverman HS. Sodium channel blockade reduces hypoxic sodium loading and sodium dependent calcium loading. Circulation 1994; 90:391–399.
25
22. Singh RB, Niaz MA, Agarwal P, Beegum R, Rastogi SS, Sachan DS. A randomised, double-blind, placebo-controlled trial of L-carnitine in suspected acute myocardial infarction. Postgrad Med J 1996; 72:45-50.
26
23. Xue YZ, Wang LX, Liu HZ, Qi XW, Wang XH, Ren HZ. L-carnitine as an adjunct therapy to percutaneous coronary intervention for non-ST elevation myocardial infarction. Cardiovasc Drugs Ther 2007; 21:445-448.
27
24. Keller VA, Toporoff B, Raziano RM, Pigott JD, Mills NL. Carnitine supplementation improves myocardial function in hearts from ischemic diabetic and euglycemic rats. Ann Thorac Surg 1998; 66:1600-1603.
28
25. Broderick TL, Panagakis G, DiDomenico D, Gamble J, Lopaschuk GD, Shug AL,
29
. L-carnitine improvement of cardiac function is associated with a stimulation in glucose but not fatty acid metabolism in carnitine-deficient hearts. Cardiovasc Res 1995; 30:815-820.
30
26. Broderick TL, Cifuentes J, Green D, Paulson DJ. Short-term carnitine deficiency does not alter aerobic rat heart function but depresses reperfusion recovery after ischemia. Can J Physiol Pharmacol 2001; 79:892-897.
31
27. Colonna P, Iliceto S. Myocardial infarction and left ventricular remodeling: results of the CEDIM trial, Carnitine Ecocardiografia Digitalizzata Infarto Miocardico. Am Heart J 2000; 139:S124-130.
32
28. Tarantini G, Scrutinio D, Bruzzi P, Boni L, Rizzon P, Iliceto S. Metabolic treatment with L-carnitine in acute anterior ST segment elevation myocardial infarction. A randomized controlled trial. Cardiology 2006;106:215-223.
33
ORIGINAL_ARTICLE
The Comparison of Proteins Elaborated by Streptococcus mutans Strains
Isolated from Caries Free and Susceptible Subjects
https://ijbms.mums.ac.ir/article_726_2fba4e030c9d471c106ec31e4f7b3c52.pdf
2013-04-01
656
660
10.22038/ijbms.2013.726
Caries free
Caries susceptible
Protein pattern
SDS-PAGE
Streptococcus mutans
Arezoo
Tahmourespour
atahmoures@khuisf.ac.ir
1
Khorasgan-Isfahan Branch, Islamic Azad University, Isfahan, Iran
AUTHOR
Abdolreza
Nabinejad
2
Razi vaccine & serum Research Institute, Isfahan Branch (Vet Dept of Agriculture), Amirhamzeh, Isfahan, Iran
AUTHOR
Hannaneh
Shirian
3
Razi vaccine & serum Research Institute, Isfahan Branch (Vet Dept of Agriculture), Amirhamzeh, Isfahan, Iran
AUTHOR
Nafiseh
hasemipero
4
Biotechnology Research Lab, Khorasgan-Isfahan branch, Islamic Azad University, Isfahan, Iran
AUTHOR
Becker MR, Paster BJ, Leys EJ, Moeschberger ML, Kenyon SG, Galvin JL, et al
1
. Molecular analysis of bacterial species associated with childhood caries. J Clin Microbiol 2002; 40: 1001-1009.
2
2. Kamiya RU, Napimoga MH, Hofling JF, Goncalves RB. Frequency of four different mutacin genes in
3
Streptococcus mutans
4
genotypes isolated from caries-free and caries-active individuals, J Med Microbiol 2005; 54: 599-604.
5
3. Baca P, Castillo AM, Baca AP, Liebana MJ, Junco P, Liebana J. Genotypes of
6
Streptococcus mutans
7
in saliva versus dental Plaque. Arch Oral Biol 2008; 53: 751-754.
8
4. Tahmourespour A, Kermanshahi RK. The effect of a probiotic strain (
9
Lactobacillus acidophilus
10
) on the plaque formation of oral Streptococci. Bosn J Basic Med Sci 2011; 1: 38-40.
11
5. Simonson LG, Shklair IL. Gel Electrophoresis of Intracellular Components of Some Cariogenic Streptococci. J Dent Res 1972; 51: 488-491.
12
6. Vos P, Hogers R, Bleeker M, Reijans M, van der Lee T, Hornes M,
13
. AFLP: a new technique for DNA fingerprinting. Nucleic Acids Res 1995; 23: 4407-4414.
14
7. Durrani R, Abubakar M, Javed Arshed M, Saleha S, Ullah I, Qurban A. Biological characterization and protein profiles of two model bacteria by SDS-PAGE and FT-IR. ARPN J Agri and Biol Sci 2008; 3: 5-6.
15
8. Najaphy A, Niari khamssi N, Mostafaie A, Mirzaee H. Effect of progressive water deficit stress on proline accumulation and protein profiles of leaves in chickpea. Afr J Biotech 2010; 9(42): 7033-7036.
16
9. Leisner JJ, Millan JC, Huss HH, Larsen LM. Production of Histamine and tyramine by Lactic Acid bacteria isolated from Vacuum packed sugar-salted fish. J Appl Bacteriol 1994; 76: 417-423.
17
10. Heidarian E, Haghighi B. Evidence for Histidine Residues on Plasma Membrane Phosphatidate. Iran J Basic Med Sci 2008; 11(3):166- 73.
18
11. Ahmadabad HN, Zuhair M H, Safari E, Bozorgmehr M, Moazzeni M. Evaluation of the Effect of the 47 kDa Protein Isolated from Aged Garlic Extract on Dendritic Cells. Iran J Basic Med Sci 2012; 15(2): 742-51.
19
12. Rosa RT, Napimoga MH, Hofling JF, Gonçalves RB, Rosa EAR. (2005) Clonal Diversity of
20
Streptococcus Clarke
21
(1924) in caries-free adults. Estud Biolog 27:49-51.
22
13. Tahmourespour A, Kermanshahi RK, Salehi R, Nabinejad A. (2008). The Relationship between Cell Surface Hydrophobicity and Antibiotic Resistance of Streptococcal Strains Isolated from Dental Plaque and Caries. Iran J Basic Med Sci 10(4):251-255.
23
14. Selander RK, Caugant DA, Ochman H, Musser JM, Gilmour MN, Whittam TS. Methods of multilocus enzyme electrophoresis for bacterial population genetics and systematic. Appl environ microbiol 1986; 873-884.
24
15. Lowry OH, Roseborough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265- 275.
25
16. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (London) 1970; 227: 680-685.
26
17. Johnson RA, Wichernd W. Classification and grouping techniques. In Applied Multivariate Statistical Analysis, Edited by R. A. Johnson & D. W. Wichern. London: Prentice-Hall; 1982, pp. 459- 478.
27
18. Piraino P, Ricciardi A, Salzano G, Zotta T, Parente E. Use of unsupervised and supervised artificial neural networks for the identification of lactic acid bacteria on the basis of SDS-PAGE patterns of whole cell proteins. J Microbiol Meth 2006; 66(2): 336-346.
28
19. Perrone M, Gfell LE, Fontana M, Gregory RL. Antigenic Characterization of Fimbria Preparations from
29
Streptococcus mutans
30
Isolates from Caries-Free and Caries-Susceptible Subjects. Clin Diagn Lab Immunol 1997; 291-296.
31
20. Welin J, Wilkins JC, Beighton D, Svensater G. Protein Expression by
32
Streptococcus mutans
33
during Initial Stage of Biofilm Formation. Appl Environ Microbiol 2004; 3736-3741.
34
21. Ogunjobi AA, Dixon AGO, Fagade O E, Ogunjobi AA, Dixon AGO, Fagade OE. Molecular genetic study of Cassava bacterial blight casual agent in Nigeria. Elec J Environ Agri & food Chem 2007;6(9): 2364-76.
35
22. Razaghi A, Hasanzadeh N, Ghasemi A. Characterization of
36
Xanthomonas citri subsp. malvacearum
37
strains in Iran. Afr J Microbiol Res 2012; 6(6):1165-70.
38
23. Abbasi V, Rahimian H, Tajic-ghanbari MA, Rezaian V. The assessment of genetic diversity of strains of
39
Pseudomonas syringae pv. syringae
40
causing bacterial canker in stone fruits. Iran J Plant Path 2011; 47(4): 133-135.
41
24. Gronroos L, Alaluusua S. Site-specific oral colonization of mutans streptococci detected by arbitrarily primed PCR fingerprinting. Caries Res 2000; 34: 474-480.
42
25. Napimoga MH, Kamiya RU, Rosa RT, Rosa EAR, jose Hofling F, de Oliveira Mattos-Graner R,
43
et al. Genotypic diversity and virulence traits of Streptococcus mutans
44
in caries free and caries active individuals. J medical Microbiol 2004; 53: 697-703.
45
26. Kamiya RU, Napimoga MH, Rosa RT, Hofling JF, Goncalves RB. Mutacin production in
46
Streptococcus mutans
47
genotypes isolated from caries-affected and caries-free individuals. Oral Microbiol Immunol 2005; 20: 20-24.
48
27. Alaluusua S, Matto J, Gronroos L, Innila S, Torkko H, Asikainen S. Oral colonization by more than one clonal type of mutans streptococcus in children with nursing- bottle dental caries. Arch Oral Biol 1996; 41: 167-173.
49
28. Kreulen CM, de Soet HJ, Hogeveen R, Veerkamp JSJ.
50
Streptococcus mutans
51
in children using nursing bottles. ASDC J Dent Child 1997; 64: 107-111.
52
ORIGINAL_ARTICLE
Apoptosis Induced by 13-S-hydroxyoctadecadienoic acid in the Breast
Cancer Cell Lines, MCF-7 and MDA-MB-231
https://ijbms.mums.ac.ir/article_727_f031359fc84345da018a465fab2d17e6.pdf
2013-04-01
661
667
10.22038/ijbms.2013.727
Keywords:
Apoptosis
MCF-7
MDA-MB-231
PPAR-δ
13-S-hydroxyoctadecadienoic acid
Masoumeh
Tavakoli-Yaraki
masoumeh.tavakoli@gmail.com
1
Department of Clinical Biochemistry, Cancer Research Laboratory, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran
AUTHOR
Fatemeh
Karami-Tehrani
2
Department of Clinical Biochemistry, Cancer Research Laboratory, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran
AUTHOR
1. Lambrechts S, Decloedt J, Neven P. Breast cancer prevention: Lifestyle
1
changes and chemoprevention. Acta Clin Belg 2011; 66:283-
2
2. Kasibhatla S, Tseng B. Why target apoptosis in cancer treatment?
3
Mol Cancer Ther 2003; 2:573-580.
4
3. Brash AR. Lipoxygenases: Occurrence, functions, catalysis, and acquisition
5
of substrate. J Biol Chem 1999; 274:23679-23682.
6
4. Brash AR, Jisaka M, Boeglin WE, Chang MS, Keeney DS, Nanney LB,
7
Investigation of a second 15s-lipoxygenase in humans and its
8
expression in epithelial tissues. Adv Exp Med Biol 1999; 469:83-
9
5. Shureiqi I, Wojno KJ, Poore JA, Reddy RG, Moussalli MJ, Spindler
10
. Decreased 13-s-hydroxyoctadecadienoic acid levels and
11
15-lipoxygenase-1 expression in human colon cancers. Carcinogenesis
12
1999; 20:1985-1995.
13
6. Yuan H, Li MY, Ma LT, Hsin MK, Mok TS, Underwood MJ, Chen GG.
14
15-lipoxygenases and its metabolites 15(s)-hete and 13(s)-hode
15
in the development of non-small cell lung cancer. Thorax 2010;
16
65:321-326.
17
7. Nixon JB, Kim KS, Lamb PW, Bottone FG, Eling TE. 15-lipoxygenase-1
18
has anti-tumorigenic effects in colorectal cancer. Prostaglandins
19
Leukot Essent Fatty Acids 2004; 70:7-15.
20
8. Xu XC, Shappell SB, Liang Z, Song S, Menter D, Subbarayan V,
21
. Reduced 15s-lipoxygenase-2 expression in esophageal cancer
22
specimens and cells and upregulation
23
by the cyclooxygenase-
24
2 inhibitor, ns398. Neoplasia 2003; 5:121-127.
25
9. Hennig R, Kehl T, Noor S, Ding XZ, Rao SM, Bergmann F,
26
15-lipoxygenase-1 production is lost in pancreatic cancer and
27
overexpression of the gene inhibits tumor cell growth. Neoplasia
28
2007; 9:917-926.
29
10. Jiang WG, Watkins G, Douglas-Jones A, Mansel RE. Reduction of isoforms
30
of 15-lipoxygenase (15-lox)-1 and 15-lox-2 in human breast
31
cancer. Prostaglandins Leukot Essent Fatty Acids 2006; 74:235-
32
11. Shureiqi I, Chen D, Lee JJ, Yang P, Newman RA, Brenner DE,
33
15-lox-1: A novel molecular target of nonsteroidal anti-inflammatory
34
drug-induced apoptosis in colorectal cancer cells. J Natl
35
Cancer Inst 2000; 92:1136-1142.
36
12. Hsi LC, Xi X, Lotan R, Shureiqi I, Lippman SM. The histone deacetylase
37
inhibitor suberoylanilide hydroxamic acid induces apoptosis
38
via induction of 15-lipoxygenase-1 in colorectal cancer cells.
39
Cancer Res 2004; 64:8778-8781.
40
13. Kumar KA, Arunasree KM, Roy KR, Reddy NP, Aparna A, Reddy GV,
41
Reddanna P. Effects of (15s)-hydroperoxyeicosatetraenoic acid
42
and (15s)-hydroxyeicosatetraenoic acid on the acute- lymphoblastic-
43
leukaemia cell line jurkat: Activation of the fas-mediated
44
death pathway. Biotechnol Appl Biochem 2009; 52:121-133.
45
14. Shureiqi I, Chen D, Lotan R, Yang P, Newman RA, Fischer SM,
46
15-lipoxygenase-1 mediates nonsteroidal anti-inflammatory
47
drug-induced apoptosis independently of cyclooxygenase-2 in
48
colon cancer cells. Cancer Res 2000; 60:6846-6850.
49
15. Shureiqi I, Wu Y, Chen D, Yang XL, Guan B, Morris JS,
50
. The critical
51
role of 15-lipoxygenase-1 in colorectal epithelial cell terminal
52
differentiation and tumorigenesis. Cancer Res 2005; 65:11486-
53
16. Pasqualini ME, Heyd VL, Manzo P, Eynard AR. Association between
54
e-cadherin expression by human colon, bladder and breast cancer
55
cells and the 13-hode:15-hete ratio. A possible role of their
56
metastatic potential. Prostaglandins Leukot Essent Fatty Acids
57
2003; 68:9-16.
58
17. Cimen I, Tuncay S, Banerjee S. 15-lipoxygenase-1 expression suppresses
59
the invasive properties of colorectal carcinoma cell lines
60
hct-116 and ht-29. Cancer Sci 2009; 100:2283-2291.
61
18. Youssef J, Badr M. Peroxisome proliferator-activated receptors
62
and cancer: Challenges and opportunities. Br J Pharmacol
63
2011;164:68-82.
64
19. Chawla A, Repa JJ, Evans RM, Mangelsdorf DJ. Nuclear receptors
65
and lipid physiology: Opening the x-files. Science 2001; 294:1866-
66
20. Foreman JE, Sharma AK, Amin S, Gonzalez FJ, Peters JM. Ligand
67
activation of peroxisome proliferator-activated receptor-beta/
68
delta (pparbeta/delta) inhibits cell growth in a mouse mammary
69
gland cancer cell line. Cancer Lett 2010; 288:219-225.
70
21. Zuo X, Wu Y, Morris JS, Stimmel JB, Leesnitzer LM, Fischer SM,
71
. Oxidative metabolism of linoleic acid modulates ppar-beta/
72
delta suppression of ppar-gamma activity. Oncogene 2006;
73
25:1225-1241.
74
22. Sigal E, Grunberger D, Highland E, Gross C, Dixon RA, Craik CS.
75
Expression of cloned human reticulocyte 15-lipoxygenase and
76
immunological evidence that 15-lipoxygenases of different cell
77
13(S)-HODE Tavakoli-Yaraki M et al
78
Iran J Basic Med Sci; Vol. 16, No. 4, Apr 2013
79
types are related. J Biol Chem 1990; 265:5113-5120.
80
23. Mahipal SV, Subhashini J, Reddy MC, Reddy MM, Anilkumar K, Roy
81
. Effect of 15-lipoxygenase metabolites, 15-(s)-hpete and
82
15-(s)-hete on chronic myelogenous leukemia cell line k-562: Reactive
83
oxygen species (ros) mediate caspase-dependent apoptosis.
84
Biochem Pharmacol 2007; 74:202-214.
85
24. Kim JH, Chang JH, Yoon JH, Lee JG, Bae JH, Kim KS. 15-lipoxygenase-1
86
induced by interleukin-4 mediates apoptosis in oral cavity cancer
87
cells. Oral Oncol 2006; 42:825-830.
88
25. Viita H, Pacholska A, Ahmad F, Tietavainen J, Naarala J, Hyvarinen
89
15-lipoxygenase-1 induces lipid peroxidation and apoptosis,
90
and improves survival in rat malignant glioma.
91
26. Glinghammar B, Skogsberg J, Hamsten A, Ehrenborg E. Ppardelta
92
activation induces cox-2 gene expression and cell proliferation
93
in human hepatocellular carcinoma cells. Biochem Biophys Res
94
Commun 2003; 308:361-368.
95
27. Stephen RL, Gustafsson MC, Jarvis M, Tatoud R, Marshall BR, Knight
96
. Activation of peroxisome proliferator-activated receptor
97
delta stimulates the proliferation of human breast and prostate
98
cancer cell lines. Cancer Res 2004; 64:3162-3170.
99
28. Yin Y, Russell RG, Dettin LE, Bai R, Wei ZL, Kozikowski AP,
100
. Peroxisome
101
proliferator-activated receptor delta and gamma agonists
102
differentially alter tumor differentiation and progression during
103
mammary carcinogenesis. Cancer Res 2005; 65:3950-3957.
104
29. Ghosh M, Ai Y, Narko K, Wang Z, Peters JM, Hla T. Ppardelta is protumorigenic
105
in a mouse model of cox-2-induced mammary cancer.
106
Prostaglandins Other Lipid Mediat 2009; 88:97-100.
107
30. Glasgow WC, Hui R, Everhart AL, Jayawickreme SP, Angerman-
108
Stewart J, Han BB,
109
The linoleic acid metabolite, (13s)-hydroperoxyoctadecadienoic
110
acid, augments the epidermal growth
111
factor receptor signaling pathway by attenuation of receptor
112
dephosphorylation. Differential response in syrian hamster embryo
113
tumor suppressor phenotypes. J Biol Chem 1997; 272:19269-
114
31. Sauer LA, Dauchy RT, Blask DE, Armstrong BJ, Scalici S. 13-hydroxyoctadecadienoic
115
acid is the mitogenic signal for linoleic
116
acid-dependent growth in rat hepatoma 7288ctc
117
Res 1999; 59:4688-4692.
118
32. Kelavkar UP, Cohen C, Kamitani H, Eling TE, Badr KF. Concordant
119
induction of 15-lipoxygenase-1 and mutant p53 expression in human
120
prostate adenocarcinoma: Correlation with gleason staging.
121
Carcinogenesis 2000; 21:1777-1787.
122
33. Kelavkar UP, Nixon JB, Cohen C, Dillehay D, Eling TE, Badr KF. Overexpression
123
of 15-lipoxygenase-1 in pc-3 human prostate cancer
124
cells increases tumorigenesis. Carcinogenesis 2001; 22:1765-1773.
125
ORIGINAL_ARTICLE
Double edged effect of gum-resin of ferula assa-foetida on lifespan of
neurons
https://ijbms.mums.ac.ir/article_728_671395815dc4d8cb0e1e6ed24486f6b4.pdf
2013-04-01
668
671
10.22038/ijbms.2013.728
Keywords:
Asafoetida
Mesenchymal stem cells
Neuroprotective
Neurotoxic
Farshad
Homayouni Moghadam
f_homayounim@yahoo.com
1
Neurobiomedical Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
2 Department of Physiology, School of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
LEAD_AUTHOR
Behzad
Vakili Zarch
2
Neurobiomedical Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
AUTHOR
Mohammad
Shafiei
mohammad_shafiei@gmail.com
3
Neurobiomedical Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
AUTHOR
Iranshahy M, Iranshahi M. Traditional uses, phytochemistry
1
and pharmacology of asafoetida (Ferula assa-foetida oleo-gum-resin)-a review. J Ethnopharmacol 2011;134:1-10.
2
2. Kelsey NA, Wilkins HM, Linseman DA. Nutraceutical antioxidants as novel neuroprotective agents. Molecules 2010;15:7792-814.
3
3. Abd El-Razek MH, Ohta S, Ahmed AA, Hirata T. Sesquiterpene coumarins from the roots of Ferula assa-foetida. Phytochemistry 2001;58:1289–95.
4
4. Ishigami M, Hiraki K, Umemura K, Ogasawara Y, Ishii K, Kimura H. A source of hydrogen sulfide and a mechanism of its release in the brain. Antioxid Redox Signal 2009;11:205-14.
5
5. Akdogan I, Kocamaz E, Kucukatay V, Yonguc NG, Ozdemir MB, Murk W. Hippocampal neuron number loss in rats exposed to ingested sulfite. Toxicol Ind Health 2011;27:771-8.
6
6. Woodbury D, Schwarz EJ, Prockop DJ, Black IB. Adult rat and human bone marrow stromal cells differentiate into neurons. J Neurosci Res 2000;61:364-70.
7
7. Wislet-Gendebien S, Hans G, Leprince P, Rigo JM, Moonen G, Rogister B. Plasticity of cultured mesenchymal stem cells: switch from nestin-positive to excitable neuron-like phenotype. Stem Cells 2005;23:392-402.
8
8. Abnosi MH, Solemani Mehranjani M, Momeni M, Shojafar E, Barati M. Induction of Apoptosis in the Rat Bone Marrow Mesenchymal Stem Cells Following Sodium Arsenite Treatment with the Dose Lesser than that Used for Treatment of Malignant Patient. Iran J Basic Med Sci 2012;15:900-906.
9
Baghaban Eslaminejad M
10
, Mardpour S, Ebrahimi M. Mesenchymal Stem Cells Derived from Rat Epicardial Versus Epididymal Adipose Tissue . Iran J Basic Med Sci 2012;14:25-34.
11
Golipoor Z, Ragerdi Kashani I, Akbari M, Hassanzadeh G, Malek F, Mahmoudi R
12
. Differentiation of Adipose-derived Stem Cells into Schwann Cell Phenotype in Comparison with Bone Marrow Stem Cells. Iran J Basic Med Sci 2012;13:76-84.
13
11. Ebrahimzadeh MA, Nabavi SM, Nabavi SF, Dehpour AA. Antioxidant activity of hydroalcholic extract of Ferula gummosa Boiss roots. Eur Rev Med Pharmacol Sci 2011;15:658-64.
14
12. Chen C, Kong AN. Dietary chemopreventive compounds and ARE/EpRE signaling. Free Radic Biol Med 2004;36:1505-16.
15
13. Lu Y, Xu C, Yang Y, Pan H. [The effect of antioxidant sodium ferulate on human lymphocytes apoptosis induced by H2O2]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 1998;20:44-8.
16
14. Cheng CY, Su SY, Tang NY, Ho TY, Chiang SY, Hsieh CL. Ferulic acid provides neuroprotection against oxidative stress-related apoptosis after cerebral ischemia/reperfusion injury by inhibiting ICAM-1 mRNA expression in rats. Brain Res 2008;1209:136-50.
17
15. Motai T, Kitanaka S. Sesquiterpene phenylpropanoids from Ferula fukanensis and their nitric oxide production inhibitory effects. J Nat Prod 2005;68:365-8.
18